Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Postmortem examination after deaths in neonatal units in England and Wales, 2017-2022: a national observational study.

Archives of disease in childhood. Fetal and neonatal edition·2026
Same author

Equity and Respect in Maternal and Infant Healthcare-A Report From the 2025 Venice Forum.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Necrotizing enterocolitis.

Nature reviews. Disease primers·2026
Same author

Changes in admissions, care processes and outcomes for very and extremely preterm infants in England and Wales: an 11-year whole population study.

BMJ public health·2026
Same author

Live biotherapeutic product IBP-9414 (L. reuteri) in very low birth weight infants: the Connection Study.

Pediatric research·2026
Same author

Body composition and neonatal nutrition research.

Pediatric research·2026
Same journal

Strategies for prevention of intraventricular hemorrhage in the neonatal intensive care unit.

Seminars in fetal & neonatal medicine·2026
Same journal

Introduction.

Seminars in fetal & neonatal medicine·2026
Same journal

Introduction.

Seminars in fetal & neonatal medicine·2026
Same journal

Should inhaled nitric oxide be used for respiratory failure in preterm infants?

Seminars in fetal & neonatal medicine·2026
Same journal

Inhaled nitric oxide in premature infants for respiratory failure: Discussion and consensus.

Seminars in fetal & neonatal medicine·2026
Same journal

Critical thinking in red blood cell transfusion decisions: Donor, product, recipient, and outcomes.

Seminars in fetal & neonatal medicine·2026
查看所有相关文章

相关实验视频

Updated: Jul 8, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.4K

人母奶适用于早产婴儿

Neena Modi1

  • 1Imperial College London, Chelsea and Westminster Hospital campus, 369 Fulham Road, London, SW10 9NH, UK.

Seminars in fetal & neonatal medicine
|April 16, 2025
PubMed
概括
此摘要是机器生成的。

来自捐赠者的母乳与母亲自己的牛奶有很大的不同,这会影响早产婴儿的营养. 需要进行更多的研究,以确保在脆弱的婴儿中安全有效地使用捐赠的牛奶.

关键词:
商业化的人类牛奶产品捐赠者的牛奶是没有的.一个证据基础的证据库.人类的牛奶是人类的牛奶.婴儿早产婴儿早产婴儿发生死性肠球炎.随机对照试验是随机对照试验.

更多相关视频

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

2.2K
Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

409

相关实验视频

Last Updated: Jul 8, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.4K
Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

2.2K
Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

409

科学领域:

  • 新生儿营养新生儿营养
  • 人类牛奶的成分 人类牛奶的成分
  • 婴儿发育 婴儿发育

背景情况:

  • 人类母乳在生物学上是独一无二的,它含有营养和非营养成分,对婴儿发育至关重要.
  • 婴儿自己的母乳和捐赠或商业母乳之间存在差异.
  • 养早产婴儿的人母乳涉及处理,储存和输送方法等复杂性.

研究的目的:

  • 为了突出母亲和捐赠的母乳之间的关键区别为早产婴儿.
  • 检查关于早产新生儿捐赠母乳临床有效性和安全性的证据.
  • 用母乳识别早产婴儿营养方面的知识差距.

主要方法:

  • 关于母乳成分和早产婴儿养的当前科学文献的综述.
  • 对母乳与捐赠母乳的营养和非营养因素的分析.
  • 对临床试验数据的评估关于母乳对早产婴儿的疗效和安全性.

主要成果:

  • 在母乳和捐赠母乳之间,营养和生物活性成分的显著差异.
  • 关于早产婴儿捐赠母乳临床有效性和补充必要性的不确定性.
  • 与使用捐赠母乳相关的潜在风险,包括加工和储存的影响.

结论:

  • 人母乳的异质性需要在早产婴儿使用时仔细考虑.
  • 目前关于捐赠母乳对早产新生儿的安全性和有效性的证据不足.
  • 解决证据差距对于改善非常早产婴儿的营养护理至关重要.